Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) Return on assets

Alert me on Return on assets

Chemed Corporation's return on assets over the twelve months to 30 September 2026 was 16.9%, up 0.4 percentage points from fiscal 2025 (16.5%). Over the past ten years it has ranged from 10.9% (fiscal 2017) to 23.6% (fiscal 2020); the current reading is higher than 36% of that period. That is above the Medical Care Facilities industry median of 2.78% and above the Healthcare sector median of −29.3%.

Return on assets, annual

Embed this chart

Annual newest first

Period Return on assets Change (points)
FY2025 16.5% (1.56)
FY2024 18.1% 0.58
FY2023 17.5% (0.41)
FY2022 17.9% (1.41)
FY2021 19.3% (4.30)
FY2020 23.6% 4.04
FY2019 19.6% (2.09)
FY2018 21.7% 10.78
FY2017 10.9% (1.64)
FY2016 12.6% (0.33)

Against its own ten years

Low 10.9% High 23.6%
Ten-year median 17.9%
Current reading's percentile 36

Return on assets against peers

What Return on assets is

ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.

Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)

The full definition of Return on assets →

More on CHE